News
1d
Zacks Investment Research on MSNNovo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to NoteIn the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...
8d
Zacks Investment Research on MSNNovo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on ItNovo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of ...
TEM surges 91.8% YTD on rapid AI-healthcare growth, while NVDA fuels the sector with cutting-edge infrastructure and partnerships.
2don MSNOpinion
Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Kumar now believes the stock is only worthy of a hold recommendation, down from his previous assessment of buy. He also significantly lowered his price target, chopping it to 360 Danish krone ($55.49) ...
Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...
Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival ...
23h
Zacks.com on MSNRegeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales UpDetailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Novo Nordisk A/S and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results